The RBI has reportedly issued a directive requiring observers on the boards of NBFCs to be appointed as directors. This significant shift will affect how investors engage with the management of their ...
Over the past couple of months, the medical devices sector in India has witnessed significant developments, with the Central Drugs Standard Control Organisation successfully obtaining affiliate membership of the International Medical Device Regulators Forum to Strengthen Medical Device Regulations. In addition, India has further solidified its status as a major player in the global vaccine market, with the National Regulatory Authority of India successfully meeting standards for vaccine regulation prescribed by the World Health Organisation. Other key developments such as recent amendments brought to the Drugs and Cosmetics Rules, 1945 by the Ministry of AYUSH and the continued efforts of the Department of Pharmaceuticals to successfully implement the Uniform Code of Marketing Practices in Medical Devices have dominated headlines in the space.
Against this backdrop, INDUSLAW’s Shantanu Jindel, Shweta Gupta, Harshit Kumar, Vatsal Agarwal and Abhinav present you this edition of ‘Checking the Pulse’, delving into key updates from October 2024 to November 2024 in the healthcare and pharmaceutical sectors, while also tapping on notable deals that have gained interest from the industry.
